Variants in clock genes could be associated with lower risk of type 2 diabetes in an elderly Greek population
Section snippets
1. Introduction
Type 2 diabetes (T2D) is a chronic disorder of glucose metabolism, related to impaired quality of life, severe complications, and significant burden for health care systems, that tends to be a global epidemic [1]. The International Diabetes Federation estimates that the number of people living with the disease globally is expected to reach 700 million by 2045 [2]. T2D confers a four-fold greater risk for the development of cardiovascular (CV) disease compared to the non-diabetic status [3] and
2.1. Study population
Participants aged over 65 years with an established T2D diagnosis (group A) were recruited from two major, Greek, academic diabetes centers, namely AHEPA University Hospital of Thessaloniki and General University Hospital of Alexandroupolis. The diagnosis of diabetes was established according to the criteria of the American Diabetes Association [17]. Exclusion criteria for the diabetes group were severe hepatic disease and treatment with drugs that might affect blood glucose, including
3.1. Study population characteristics
A total of 1285 participants were enrolled in the study. Of these, 716 individuals with T2D were included in group A, whereas groups B and C consisted of 569 and 393 controls, respectively. Females predominated in all groups: A (52 vs. 48%), B (62 vs. 38%) and C (60 vs. 40%). Mean age of participants in groups A, B and C was 68.93 ± 9.53, 73.46 ± 7.25 and 74.00 ± 11.00 years respectively (p<0.05), whereas diabetes duration was 14.39 ± 9.29 years. As expected, patients with T2D had higher body
4. Discussion
To the best of our knowledge, this is the first study to investigate the relationship between variants in clock genes and the risk of developing T2D in the Greek population. Implementation of permutation test analysis enabled us to estimate empirical p-values and reveal potential associations between variation in PPARA, PPARD, PKDRJ, UTS2, CLOCK/TMEM165 and VAMP2 genes and T2D. Our results mostly imply a protective role of SNPs in these genes against the disorder.
It is worth noting that the
Contributors
Xanthippi Tsekmekidou carried out the implementation and wrote the manuscript.
Fotis Tsetsos designed the model and the computational framework and analyzed the data.
Theocharis Koufakis wrote the manuscript.
Marianthi Georgitsi carried out the implementation.
Nikolaos Papanas assisted with control group collection.
Dimitrios Papazoglou assisted with control group collection.
Athanasios Roumeliotis assisted with patient enrollment and study measurements.
Stylianos Panagoutsos assisted with patient
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES. Investing in knowledge society through the European Social Fund (MIS 380273). This work was also supported in part by Hellenic Association for the Study and Education of Diabetes Mellitus.
Ethical approval
The study protocol was approved by the Ethics Committee of the Aristotle University of Thessaloniki. Written informed consent was obtained from all participants. All procedures were in accordance with the 1964 Helsinki declaration for research in humans and its later revisions.
Provenance and peer review
This article was not commissioned and was externally peer reviewed.
Research data (data sharing and collaboration)
There are no linked research data sets for this paper. Data will be made available on request.
References (37)
- et al.
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Lancet
(2014) - et al.
Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategies
Maturitas
(2021) - et al.
Clock genes, pancreatic function, and diabetes
Trends Mol. Med.
(2014) - et al.
TMEM165 deficiency causes a congenital disorder of glycosylation
Am. J. Hum. Genet.
(2012) - et al.
Phenotyping of PER3 variants reveals widespread effects on circadian preference, sleep regulation, and health
Sleep Med. Rev.
(2018) - et al.
PLINK: a tool set for whole-genome association and population-based linkage analyses
Am. J. Hum. Genet.
(2007) - et al.
Circadian regulation of islet genes involved in insulin production and secretion
Mol. Cell. Endocrinol.
(2004) - et al.
Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose
Eur. J. Pharmacol.
(2009) - et al.
Nuclear Receptor Expression Links the Circadian Clock to Metabolism
Cell
(2006) - et al.
Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c
Int. J. Cardiol.
(2016)
Global and Regional Diabetes Prevalence Estimates For 2019 and Projections For 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Lancet
Projections of global mortality and burden of disease from 2002 to 2030
PLoS Med
Synchronization of biological clock neurons by light and peripheral feedback systems promotes circadian rhythms and health
Front. Neurol.
Adverse metabolic and cardiovascular consequences of circadian misalignment
Proc. Natl. Acad. Sci. U. S. A.
Shift work and the risk of cardiovascular disease. A systematic review and meta-analysis including dose-response relationship
Scand. J. Work. Environ. Heal.
Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction
J. Biol. Rhythms.
Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man
Int. J. Obes.
Cited by (1)
A systematic review of variations in circadian rhythm genes and type 2 diabetes
2024, Nutrition and Health